PenderFund Capital Management’s Cidara Therapeutics CDTX Stock Holding History

PenderFund Capital Management’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-900	Closed	-$199K	–	264
2025 Q4	$199K	Buy	+900	New	+$145K	0.03%	125

PenderFund Capital Management's CDTX Position: Q1 2026 in Review

PenderFund Capital Management sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 900 shares — an estimated $199K sold.

PenderFund Capital Management first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $199K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

PenderFund Capital Management reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
PenderFund Capital Management sold 900 Cidara Therapeutics shares in Q1 2026, an estimated $199K.
PenderFund Capital Management first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
PenderFund Capital Management's Cidara Therapeutics position peaked at $199K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on PenderFund Capital Management's 13F filing for Q1 2026, filed 15 May 2026.